KORU Medical Systems logo
Celebrating dedication and innovation in Primary Immunodeficiencies care

World Primary Immunodeficiencies (PI) Week, April 22–29, 2026

World PI Week is a global campaign dedicated to raising awareness of PI. Explore how we can work together to improve patients’ lives through timely access to quality care.

Empowering people living with primary immunodeficiency diseases with the freedom to truly live.

In the U.S. alone, primary immunodeficiency diseases (PID) affects about 270,000 people.1 Approximately 70,000 (26%) of them receive immunoglobulin (Ig) therapy.2

The Freedom™ Infusion System helps many of these patients receive subcutaneous infusions of Hizentra®, HyQvia®*, Cuvitru®, Cutaquig®, or Xembify® in the comfort of their homes, using either the large volume Freedom60® or smaller volume FreedomEDGE® pumps.

*Outside US only

Resources for patients and caregivers

KORU is proud to support people living with PID and their caregivers. Here are a few organization that serve this community.

World PI Week

World primary immunodeficiencies (PI) Week offers an opportunity to inform and educate health policy-makers, schools and families, and the general public about PI to drive the earliest possible diagnosis and optimal treatment.
www.worldpiweek.org/

IDF Resource Center

The Immune Deficiency Foundation’s online Resource Center has an abundance of materials and tools to help patients and family members of those with Primary Immunodeficiencies stay informed.
www.primaryimmune.org/resource-center

IG Living

Join the immune globulin community with access to IG Living magazine, advocacy groups, expert opinions, and patients with rare diseases.
www.igliving.com

Jeffrey Modell Foundation

The Jeffrey Modell Foundation directs efforts toward early diagnosis, meaningful treatments, equal access to care, and ultimately, a cure for Primary Immunodeficiency.
www.info4pi.org

Koru’s Patient Support Program is dedicated to supporting your success with at-home subcutaneous infusion therapy.
Download the Freedom Journey flyer

Enhancing the infusion experience of people with PID

We are constantly striving to improve the infusion experience of people with PID who receive home-based infusions. Download our posters to see the full study findings.

Enhancing efficiency in home-based subcutaneous immunoglobulin therapy

Comparing two SC pumps used for SCIg therapy

Enhancing drug adherence and patient outcomes

Additional Scientific Studies

Read these important studies deepening our understanding of PID and Ig infusion therapy.

    
  • Berger M. Subcutaneous immunoglobulin replacement in primary immunodeficiencies. Clin Immunol. 2004;112(1):1-7. doi:10.1016/j.clim.2004.02.002
  • Rojavin MA, Hubsch A, Lawo JP. Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency. J Clin Immunol. 2016;36(3):210-219. doi:10.1007/s10875-016-0243-z
  • Shrestha P, Karmacharya P, Wang Z, Donato A, Joshi AY. Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: A systematic review and meta-analysis of clinical studies. World Allergy Organ J. 2019;12(10):100068. Published 2019 Oct 9. doi:10.1016/j.waojou.2019.100068

Meet the Koru team at meetings and conferences for the PID community

Book a Demo

IDF

June 25 – 27, 2026

San Antonio, Texas

IDF Logo

ESID

October 14 – 17, 2026

Maastricht, The Netherlands

IgNS National Conference

October 15 – 18, 2026

Las Vegas, NV 

References

  1. Immune Deficiency Foundation
  2. Data on File, KORU Medical Systems Inc.

Sign up for newsletter